23 May 2013
Keywords: medarex, twelve, deal, cancer, companies, entered, into
Article | 22 January 2001
US companies Medarex and B Twelve have entered into an agreement for theR&D and commercialization of novel cancer therapeutics ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
22 May 2013
© 2013 thepharmaletter.com